Validated high-performance liquid chromatographic assay for simultaneous determination of dacarbazine and the plasma metabolites 5-(3-hydroxymethyl-3-methyl-1-triazeno) imidazole-4-carboxamide and 5-(3-methyl-1-triazeno) imidazole-4-carboxamide
スポンサーリンク
概要
- 論文の詳細を見る
- 2001-04-15
著者
-
REID Joel
Department of Oncology, Division of Developmental Oncology Research, Mayo Clinic and Foundation
-
AMES Matthew
Department of Oncology, Division of Developmental Oncology Research, Mayo Clinic and Foundation
-
Reid Joel
Department Of Oncology Division Of Developmental Oncology Research Mayo Clinic And Foundation
-
Ames Matthew
Department Of Oncology Division Of Developmental Oncology Research Mayo Clinic And Foundation
-
SAFGREN Stephanie
Department of Oncology, Division of Developmental Oncology Research, Mayo Clinic and Foundation
-
RIOS Robert
Department of Oncology, Division of Developmental Oncology Research, Mayo Clinic and Foundation
-
Rios Robert
Department Of Oncology Division Of Developmental Oncology Research Mayo Clinic And Foundation
-
Safgren Stephanie
Department Of Oncology Division Of Developmental Oncology Research Mayo Clinic And Foundation
関連論文
- LC-MS/MS assay and dog pharmacokinetics of the dimeric pyrrolobenzodiazepine SJG-136 (NSC 694501)
- Validated high-performance liquid chromatographic assay for simultaneous determination of dacarbazine and the plasma metabolites 5-(3-hydroxymethyl-3-methyl-1-triazeno) imidazole-4-carboxamide and 5-(3-methyl-1-triazeno) imidazole-4-carboxamide